IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 51 filers reported holding IGM BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $661,211 | -9.5% | 79,187 | 0.0% | 0.00% | – |
| Q2 2023 | $730,896 | +65451.2% | 79,187 | -2.4% | 0.00% | – |
| Q1 2023 | $1,115 | -21.1% | 81,169 | -2.3% | 0.00% | -100.0% |
| Q4 2022 | $1,414 | -99.9% | 83,104 | +83.9% | 0.00% | – |
| Q3 2022 | $1,027,000 | -35.0% | 45,184 | -48.5% | 0.00% | -100.0% |
| Q2 2022 | $1,581,000 | +276.4% | 87,689 | +232.0% | 0.00% | – |
| Q1 2022 | $420,000 | -40.0% | 26,412 | +10.6% | 0.00% | – |
| Q4 2021 | $700,000 | -65.6% | 23,882 | -22.9% | 0.00% | -100.0% |
| Q3 2021 | $2,035,000 | -38.2% | 30,956 | -21.8% | 0.00% | 0.0% |
| Q2 2021 | $3,295,000 | +30.8% | 39,607 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $2,520,000 | -3.7% | 32,860 | +10.9% | 0.00% | 0.0% |
| Q4 2020 | $2,616,000 | -31.7% | 29,630 | -42.9% | 0.00% | 0.0% |
| Q3 2020 | $3,828,000 | -3.9% | 51,853 | -4.9% | 0.00% | -50.0% |
| Q2 2020 | $3,982,000 | +269.4% | 54,546 | +184.2% | 0.00% | +100.0% |
| Q1 2020 | $1,078,000 | +261.7% | 19,196 | +145.5% | 0.00% | – |
| Q4 2019 | $298,000 | – | 7,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |